JP2015513527A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513527A5
JP2015513527A5 JP2014556692A JP2014556692A JP2015513527A5 JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5 JP 2014556692 A JP2014556692 A JP 2014556692A JP 2014556692 A JP2014556692 A JP 2014556692A JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5
Authority
JP
Japan
Prior art keywords
protein
peptide
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014556692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015513527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/025213 external-priority patent/WO2013119863A1/en
Publication of JP2015513527A publication Critical patent/JP2015513527A/ja
Publication of JP2015513527A5 publication Critical patent/JP2015513527A5/ja
Pending legal-status Critical Current

Links

JP2014556692A 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用 Pending JP2015513527A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US61/596,156 2012-02-07
US201261734886P 2012-12-07 2012-12-07
US61/734,886 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (2)

Publication Number Publication Date
JP2015513527A JP2015513527A (ja) 2015-05-14
JP2015513527A5 true JP2015513527A5 (enExample) 2016-03-24

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014556692A Pending JP2015513527A (ja) 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用

Country Status (13)

Country Link
US (1) US10428124B2 (enExample)
EP (1) EP2812026A4 (enExample)
JP (1) JP2015513527A (enExample)
KR (1) KR20140129124A (enExample)
CN (1) CN104203277A (enExample)
AU (1) AU2013216993C1 (enExample)
BR (1) BR112014019504A2 (enExample)
CA (1) CA2864084A1 (enExample)
EA (1) EA201491481A1 (enExample)
HK (1) HK1204929A1 (enExample)
IN (1) IN2014MN01513A (enExample)
MX (1) MX2014009285A (enExample)
WO (1) WO2013119863A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
EA201691028A1 (ru) 2013-11-20 2017-01-30 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
CN105848677B (zh) 2013-12-23 2020-01-31 爱尔开-阿贝优公司 在治疗尘螨过敏症中的肽组合及其用途
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
WO2016056596A1 (ja) * 2014-10-07 2016-04-14 日本電気株式会社 Hsp70由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
US10526388B2 (en) 2015-03-09 2020-01-07 Cytlimic Inc. Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
AU2016244570B2 (en) 2015-04-07 2020-08-27 Nec Corporation Medicine
CN109415741A (zh) * 2016-05-03 2019-03-01 Sqz生物技术公司 细胞内递送生物分子以诱导耐受性
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
KR20260017488A (ko) * 2017-04-28 2026-02-05 호유 가부시키가이샤 알레르기 항원 및 그 에피토프
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ES2384045T3 (es) * 2002-06-25 2012-06-28 Merck Patent Gmbh Secuencia de ADN y preparación recombinante del alérgeno del polen de gramíneas PHI P 4
US7731970B2 (en) 2002-08-19 2010-06-08 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
WO2006076423A2 (en) 2005-01-12 2006-07-20 Monsanto Technology, Llc Genes and uses for plant improvement
SI2244734T1 (sl) * 2008-02-01 2016-11-30 Murdoch Childrens Research Institute Postopek induciranja tolerance na alergen
EP2388268A1 (en) 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
BR112013009068A2 (pt) 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
CA2868469A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ/エスAlk−Abello A/S 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Similar Documents

Publication Publication Date Title
JP2013172734A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
NZ621868A (en) Growth hormone polypeptides and methods of making and using same
HRP20220717T1 (hr) Modificirani pripravci mrna
HRP20192314T1 (hr) Pripravci faktora viii i postupci pripreme i njihove uporabe
JP2015514395A5 (enExample)
WO2014207708A3 (en) Amino acid and peptide conjugates and conjugation process
NZ733168A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2015525217A5 (enExample)
WO2011113819A3 (en) Diagnosis and treatment of cancer based on avl9
BRPI0910461B8 (pt) hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso
RU2016146198A (ru) Терапевтические dll4-связывающие белки
HRP20161608T1 (hr) Modificirani tuberkulozni antigeni
EP3363458A3 (en) A peptide
EA201591213A1 (ru) Вакцины против вируса гепатита b
WO2017145097A3 (en) Amino acid and peptide conjugates and conjugation process
RU2016107873A (ru) Пептиды
JP2016536357A5 (enExample)
WO2013021284A3 (en) Anti-il-6 vaccine composition
RU2019113989A (ru) Лекарственное средство
JP2016515123A5 (enExample)
NZ596501A (en) Casb7439 constructs
JP2013529178A5 (enExample)
MX2017008406A (es) Conjugados de aminoacidos y peptidos y sus usos.